
    
      Study Hypothesis: Patients receiving double-dose compared with standard-dose clopidogrel will
      have increased blood concentrations of the active metabolite of clopidogrel and greater
      inhibition of ADP-induced platelet aggregation when also treated with acetylsalicylic acid
      (ASA) 325 mg/d as compared to ASA 81 mg/d.
    
  